학술논문

Preliminary results of a randomized phase II study of paclitaxel and bevacizumab +/- gemcitabine as first-line treatment for metastatic breast cancer
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2009, 27 15, 2p. Supplement: S
Subject
Language
English
ISSN
0732183X